Anti-SSBP2 monoclonal antibody
Pre-made anti-SSBP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SSBP2/SSBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1821-Ab-1/ GM-Tg-hg-IP1821-Ab-2 | Anti-Human SSBP2 monoclonal antibody | Human |
GM-Tg-rg-IP1821-Ab-1/ GM-Tg-rg-IP1821-Ab-2 | Anti-Rat SSBP2 monoclonal antibody | Rat |
GM-Tg-mg-IP1821-Ab-1/ GM-Tg-mg-IP1821-Ab-2 | Anti-Mouse SSBP2 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1821-Ab-1/ GM-Tg-cynog-IP1821-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SSBP2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1821-Ab-1/ GM-Tg-felg-IP1821-Ab-2 | Anti-Feline SSBP2 monoclonal antibody | Feline |
GM-Tg-cang-IP1821-Ab-1/ GM-Tg-cang-IP1821-Ab-2 | Anti-Canine SSBP2 monoclonal antibody | Canine |
GM-Tg-bovg-IP1821-Ab-1/ GM-Tg-bovg-IP1821-Ab-2 | Anti-Bovine SSBP2 monoclonal antibody | Bovine |
GM-Tg-equg-IP1821-Ab-1/ GM-Tg-equg-IP1821-Ab-2 | Anti-Equine SSBP2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1821-Ab-1/ GM-Tg-hg-IP1821-Ab-2; GM-Tg-rg-IP1821-Ab-1/ GM-Tg-rg-IP1821-Ab-2; GM-Tg-mg-IP1821-Ab-1/ GM-Tg-mg-IP1821-Ab-2; GM-Tg-cynog-IP1821-Ab-1/ GM-Tg-cynog-IP1821-Ab-2; GM-Tg-felg-IP1821-Ab-1/ GM-Tg-felg-IP1821-Ab-2; GM-Tg-cang-IP1821-Ab-1/ GM-Tg-cang-IP1821-Ab-2; GM-Tg-bovg-IP1821-Ab-1/ GM-Tg-bovg-IP1821-Ab-2; GM-Tg-equg-IP1821-Ab-1/ GM-Tg-equg-IP1821-Ab-2 |
Products Name | Anti-SSBP2 monoclonal antibody |
Format | mab |
Target Name | SSBP2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SSBP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1821-Ag-1 | Recombinant multi-species SSBP2/ HSPC116/ SOSS-B2 protein |
Target information
Target ID | GM-IP1821 |
Target Name | SSBP2 |
Gene ID | 23635,66970,361877,711752,479160,101088719,616564,100073250 |
Gene Symbol and Synonyms | 1500004K09Rik,2310079I02Rik,9330163K02Rik,A830008M03Rik,HSPC116,RGD1562968,SOSS-B2,SSBP2,SSDP2 |
Uniprot Accession | P81877 |
Uniprot Entry Name | SSBP2_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000145687 |
Target Classification | N/A |
The target: SSBP2, gene name: SSBP2, also named as HSPC116, SOSS-B2. This gene encodes a subunit of a protein complex that interacts with single-stranded DNA and is involved in the DNA damage response and maintenance of genome stability. The encoded protein may also play a role in telomere repair. A variant of this gene may be associated with survival in human glioblastoma patients. [provided by RefSeq, Sep 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.